Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled time : 12:03 save search
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
Published: 2021-03-08 (Crawled : 12:03) - globenewswire.com
KRON | $1.03 -0.96% -2.97% 210K
|
Health Technology
|
| O: 2.62%
H: 2.21%
C: -1.47%
ATHA | $2.06 -2.37% -1.93% 190K
|
Health Technology
|
| O: 0.1%
H: 3.28%
C: -0.31%
pharma
HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life Sciences Conference
Published: 2021-03-03 (Crawled : 12:03) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 170K
|
Health Technology
|
| O: 0.84%
H: 2.09%
C: 0.33%
GILD | News | $66.16 -1.15% -1.16% 4.9M
|
Health Technology
|
| O: -0.35%
H: 0.85%
C: -0.06%
life science pharma
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
Published: 2021-03-02 (Crawled : 12:03) - globenewswire.com
ATHA | $2.06 -2.37% -1.93% 190K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.57%
life science pharma
HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
HOOK | $0.7649 0.32% 0.91% 170K
|
Health Technology
|
| O: 4.85%
H: 4.3%
C: 2.64%
svb leerink global pharma
BridgeBio Pharma, Inc. Announces Proposed Offering of $400 Million Convertible Senior Notes
Published: 2021-01-25 (Crawled : 12:03) - globenewswire.com
BBIO | $24.95 -0.12% 0.0% 2.2M
|
Health Technology
|
| O: -2.91%
H: 1.55%
C: -2.48%
offering pharma
aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
Published: 2021-01-07 (Crawled : 12:03) - globenewswire.com
LIFE | $1.62 1.89% 2.15% 280K
|
Health Technology
|
| O: -0.27%
H: 7.03%
C: 4.31%
conference presentation pharma
Ocuphire Pharma Initiates LYNX-1 Phase 3 Study Investigating Nyxol in Night Vision Disturbances
Published: 2021-01-05 (Crawled : 12:03) - globenewswire.com
OCUP | $1.67 -4.02% -3.88% 240K
|
Health Technology
|
| O: 1.57%
H: 7.59%
C: 6.19%
phase 3 pharma
aTyr Pharma Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary Sarcoidosis
Published: 2020-12-21 (Crawled : 12:03) - globenewswire.com
LIFE | $1.62 1.89% 2.15% 280K
|
Health Technology
|
| O: 0.74%
H: 8.56%
C: 3.91%
trial phase 1b phase 2b enroll pharma
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.